Find policies, billing codes, payers, states, and providers
CPT 96542: Chemotherapy via Intraventricular or Subcutaneous Reservoir
Headline: CPT code 96542 covers chemotherapy delivered via implanted intraventricular or subcutaneous reservoirs
Lead: CPT code 96542 identifies the clinical procedure in which a provider administers chemotherapy through an intraventricular or subcutaneous reservoir. The code captures a specialized route of antineoplastic delivery used in select oncology patients and is relevant for hospital and ambulatory infusion settings nationwide.
What this represents and why it matters: CPT code 96542 documents direct administration of chemotherapy into an implanted reservoir, enabling targeted delivery for patients who require intraventricular or subcutaneous access. Accurate coding affects clinical documentation, billing, and tracking of specialized infusion services across care settings.
Key payers covered: This analysis includes national payers commonly used for benchmarking and coverage review: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: The publication provides benchmarks and billing context for CPT code 96542, summarizes clinical and service-line implications, and outlines payer coverage considerations and coding context. It also notes where input data is missing and highlights areas for operational attention in oncology infusion and hospital settings.
Customize your policy alerts
Sign up for cpt 96542 policy alerts
Get alerted when payer policies referencing 96542 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 96542 describes administration of chemotherapy through an intraventricular or subcutaneous reservoir to treat cancer. This service involves a provider delivering antineoplastic agents directly into a reservoir implanted in the patient to enable intraventricular or subcutaneous access for chemotherapy delivery.
-
Service type: Direct chemotherapy administration via implanted reservoir
-
Typical site of service: Inpatient or outpatient hospital settings, ambulatory infusion centers, or specialty oncology clinics where implanted reservoirs are accessed and chemotherapy is administered
Data not available in the input.